RASP (Actavia Life Sciences) Common Stock: $0.77 Mil (As of Mar. 2024)


What is Actavia Life Sciences Common Stock?

Actavia Life Sciences RASP -87.50% Common Stock is $0.77 Mil as of Mar. 2024.

Actavia Life Sciences's quarterly common stock stayed the same from Sep. 2023 ($0.77 Mil) to Dec. 2023 ($0.77 Mil) and stayed the same from Dec. 2023 ($0.77 Mil) to Mar. 2024 ($0.77 Mil).

Actavia Life Sciences's annual common stock increased from Sep. 2021 ($0.07 Mil) to Sep. 2022 ($0.18 Mil) and increased from Sep. 2022 ($0.18 Mil) to Sep. 2023 ($0.77 Mil).

Actavia Life Sciences Common Stock Historical Data

* Premium members only.

The historical data trend for Actavia Life Sciences's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Actavia Life Sciences Common Stock Chart

Actavia Life Sciences Annual Data
Trend Jun14 Jun15 Jun16 Mar17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.07 0.07 0.18 0.77

Actavia Life Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 0.77 0.77 0.77 0.77

Actavia Life Sciences Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.77 Mil mean?
Actavia Life Sciences (RASP) has a Common Stock of $0.77 Mil as of Mar. 2024. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Actavia Life Sciences and its competitors.
Is Actavia Life Sciences' Common Stock too high?
Actavia Life Sciences' current Common Stock is $0.77 Mil.
How does Actavia Life Sciences' Common Stock compare to BWV and FNCH?
Actavia Life Sciences' Common Stock of $0.77 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Actavia Life Sciences and its competitors. Actavia Life Sciences's current Common Stock is $0.77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Actavia Life Sciences stock overvalued right now?
Actavia Life Sciences (RASP) has a current Common Stock of $0.77 Mil. The current Common Stock is $0.77 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Actavia Life Sciences (RASP), the current Common Stock is $0.77 Mil as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Actavia Life Sciences Business Description

Address 5 Penn Plaza, No.1954, 19th Floor, New York, NY, USA, 10001
Actavia Life Sciences Inc is a clinical-stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, mainly focusing on the treatment of leukemia. Its primary indication is Acute Myeloid Leukemia (AML), which may be fatal within weeks to months, has about a 5-year survival rate of only about 25% and very poor prospects for the long-term survival of patients.